Notes / Company

Lactose (India) Ltd.

LACTOSE BSE 524202 ISIN INE058I01013 Pharmaceuticals

Fundamentals

Market cap: ₹131 cr
P/E: 21.61×
ROE: 8.79%
Debt / equity: 0.96
52-week range: 76.01 — 136.70

Research on Tijori Finance

Company snapshot

Lactose (India) Ltd.

Pharmaceuticals

₹131 cr

P/E 21.59×

Latest quarter · Mar 2026

Sales₹46 cr

Net profit₹2 cr

Op. margin+11.0%

EPS₹1.49

Strength & growth

Debt / equity0.96×

Current ratio1.28×

Sales CAGR+16.8%

EPS CAGR+3.8%

The timeline — 1 note on Lactose (India) Ltd.

June 2026

15 Jun 26 · 6:32 PM IST Brief

Brief · Credit · Micro cap

Lactose to forfeit 15 lakh warrants after SG General fails to pay

The board will consider stripping SG General Dealers LLP of its convertible warrants for non-payment. The move removes a potential dilution but also signals a counterparty default.

Verify on exchange BSE filings for LACTOSE NSE filings for LACTOSE Tijori Finance company page